Home
About
Overview
Sharing Data
ORCID
Help
History (28)
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016.
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
Survey of the Deficits in Surgeons' Knowledge of Contralateral Prophylactic Mastectomy.
Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity.
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer.
See All 28 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer.
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer. Radiology. 2024 09; 312(3):e232748.
View in:
PubMed
subject areas
Adenocarcinoma
Adult
Aged
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Neoplasm, Residual
Predictive Value of Tests
Prospective Studies
Rectal Neoplasms
Treatment Outcome
Watchful Waiting
authors with profiles
Aytekin Oto